The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Fri., Jan. 24, 7:11 AM

Slide #2. Yield10 Bioscience, Inc. (NASDAQ:YTEN) 1 for 40 Reverse Split

Announced: 1/15/2020
Stock Split: 1 for 40
Record Date: 1/15/2020
Pay Date: 1/16/2020
YTEN Optionable?: No

Yield10 Bioscience is an agricultural bioscience company focusing on the development of technologies to enable step-change increases in crop yield. Co. is developing several yield gene traits in its pipeline in canola, soybean and corn.
YTEN Detailed Information Page & Split History »

Company Name: 
Yield10 Bioscience Inc
Website: 
www.yield10bio.com
Sector: 
Biotechnology
Number of ETFs Holding YTEN: 
2
Total Market Value Held by ETFs: 
$661741
Total Market Capitalization: 
$2.00M
% of Market Cap. Held by ETFs: 
33.09%

Open the YTEN Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.33 out of 4)
51st percentile
(ranked higher than approx. 51% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.